Synapse - Mark Kris

Results (870)

Smoking history and frequency of somatic KRAS mutations in adenocarcinoma of the lung

Meeting Abstract

Miller, V. A.; Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D.; Nafa, K.; Pao, W.; Ladanyi, M.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

James, L. P.; Kris, M. G.; Heelan, R. T.; Ng, K. K.; Chia, G. H.; Gomez, J. E.; Krug, L. M.; Moore, E.; Hawkins, M. J.; Rizvi, N. A.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Long-term toxicity monitoring via electronic patient reported outcomes in end-stage chemotherapy patients

Meeting Abstract

Basch, E. M.; Iasonos, A.; Barz, A.; Culkin, A.; Kris, M. G.; Artz, D.; Fearn, P.; Speakman, J.; Scher, H. I.; Schrag, D.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I study of the antifolate pralatrexate given with vitamin B(12) and folic acid supplementation in patients (pts) with advanced non-small cell lung cancer (NSCLC)

Meeting Abstract

Azzoli, C. G.; Krug, L.; Miller, V.; Bekele, S.; Tyson, L.; Dunne, M.; Huntington, M.; Saunders, M.; Kris, M. G.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations

Meeting Abstract

Rizvi, N.; Kris, M.; Miller, V.; Krug, L.; Bekele, S.; Dowlati, A.; Rowland, K.; Tonda, M.; Mitchell, B.; Ruckdeschels, J.; more...
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)

Meeting Abstract

Riely, G. J.; Seshan, V. E.; Azzoli, C. G.; Kris, M. G.; Rusch, V. W.; Park, B. K.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma

Meeting Abstract

Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

Development of a non-small cell lung cancer (NSCLC) survivorship program: Baseline clinical characteristics and quality of life (QOL)

Meeting Abstract

Logue, A. E.; Gawiak, C. T.; Houlihan, N.; McCabe, M.; Rusch, V. W.; Kris, M.; Park, B. J.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression

Meeting Abstract

Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
Journal of Molecular Diagnostics (2007)

Fulltext@MSK | Save

Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib

Meeting Abstract

Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save